Evidence map›Paper›PMID 35939786›Full record

ArticleBlood advances2023

Distinguishing STAT3/STAT5B-mutated large granular lymphocyte leukemia from myeloid neoplasms by genetic profiling.

Mark Kavesh, Maedeh Mohebnasab, Marcela Riveros Angel, Wei Xie, Philipp W Raess, Wei Cui, Richard D Press, Guang Yang, Peng Li

Abstract read
PubMed Publisher
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Recurrent Missense Driver STAT5BAnti-cancer agents in medicinal chemistry · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mark KaveshDivision of Hematopathology, Department of Pathology, University of Utah Health, Salt Lake City, UT.
Maedeh MohebnasabDepartment of Pathology, School of Medicine, Oregon Health and Science University, Portland, OR.ORCID 0000-0001-6623-9514
Marcela Riveros AngelDepartment of Pathology, School of Medicine, Oregon Health and Science University, Portland, OR.
Wei XieDepartment of Pathology, School of Medicine, Oregon Health and Science University, Portland, OR.ORCID 0000-0003-1815-7666
Philipp W RaessDepartment of Pathology, School of Medicine, Oregon Health and Science University, Portland, OR.ORCID 0000-0002-6841-4993
Wei CuiDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, University of Kansas, Kansas City, KS.ORCID 0000-0002-8177-0538
Richard D PressDepartment of Pathology, School of Medicine, Oregon Health and Science University, Portland, OR.ORCID 0000-0002-2103-5144
Guang YangDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0002-8379-7478
Peng LiDivision of Hematopathology, Department of Pathology, University of Utah Health, Salt Lake City, UT.ORCID 0000-0003-4711-362X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Large Granular LymphocyticHumansSTAT3 Transcription FactorSTAT5 Transcription FactorSTAT3 protein, humanSTAT3 Transcription FactorSTAT5B protein, humanSTAT5 Transcription Factor

Identifiers

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.